Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer (NCT01770418)Proton Collaborative Group2013-03-01
Comparison of Intubating Condition of the Mcgrath Videolaryngoscope With and Without Muscle Relaxant (NCT02575716)Prince of Songkla University2013-03-01
IVIG in Acute Ischemic Stroke: A Pilot Study (NCT01628055)Inova Health Care Services2013-03-01
A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 (NCT01801293)Gilead Sciences2013-03-01
Whey Protein Effects on Gycemic Control and Vascular Function (NCT01814358)University of California, Los Angeles2013-03-01
Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients (NCT01606852)University of Minnesota2013-03-01
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease (NCT01769755)Celularity Incorporated2013-03-01
Multiple Ascending Dose Study in Subjects With Type 2 Diabetes (NCT01856881)Amgen2013-03-01
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (NCT01832116)University Medical Center Groningen2013-03-01
Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers (NCT01705990)International AIDS Vaccine Initiative2013-03-01
Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects (NCT01820806)Lakefront Biotherapeutics NV2013-03-01
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 (NCT02430363)Medical Research Council2013-03-01
Pediatric Cefazolin PK Study (NCT01904357)B. Braun Medical Inc.2013-03-01
Phase 1 Study of ONT-10 in Patients With Solid Tumors (NCT01556789)Cascadian Therapeutics Inc.2013-03-01
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo (NCT01827982)Janssen Research & Development, LLC2013-03-01
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367)Diane George2013-03-01
Dasatinib and Crizotinib in Advanced Cancer (NCT01744652)M.D. Anderson Cancer Center2013-03-01
Effects of Sitting Meditation and Hatha Yoga in Adolescents (NCT02339363)Alliant International University2013-03-01
Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder (NCT02055287)Luye Pharma Group Ltd.2013-03-01
An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations (NCT01575418)Ian McGowan2013-03-01
LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine (NCT01751048)National Institute of Allergy and Infectious Diseases (NIAID)2013-03-01
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients (NCT01841996)Meiji Seika Pharma Co., Ltd.2013-03-01
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization (NCT01941446)Tetraphase Pharmaceuticals, Inc2013-03-01
The Effects of Obesity on Glutathione Levels in Patients With Chronic Periodontitis Before and After Periodontal Therapy (NCT02498561)Figen ÖNGÖZ DEDE2013-03-01
Multiple Ascending Dose Study for LCB01-0371 (NCT01842516)LigaChem Biosciences, Inc.2013-03-01
Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients (NCT01747980)Protalix2013-03-01
IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee. (NCT02037204)UMC Utrecht2013-03-01
Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together (NCT01811953)Boehringer Ingelheim2013-03-01
13C-Pyruvate Breath Test (NCT01807702)University of Florida2013-03-01
Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients (NCT01825980)Novartis Pharmaceuticals2013-03-01
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose (NCT01692158)Azidus Brasil2013-03-01
Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances (NCT01903681)Neurim Pharmaceuticals Ltd.2013-03-01
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam (NCT01827540)Tobira Therapeutics, Inc.2013-03-01
A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers (NCT01814839)Alnylam Pharmaceuticals2013-03-01
Single Dose Phase I Study of FYU-981 (NCT02348307)Fuji Yakuhin Co., Ltd.2013-03-01
Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease (NCT01809275)Qu Biologics Inc.2013-03-01
Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) (NCT01808638)Silence Therapeutics GmbH2013-03-01
A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection (NCT01803308)Syneos Health2013-03-01
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A. (NCT01494779)Azidus Brasil2013-03-01
Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy (NCT01819558)Institut Paoli-Calmettes2013-03-01
An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris (NCT01785836)Allergan2013-03-01
Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer (NCT01820299)Medical University of South Carolina2013-03-01
14C-ARN-509 Microtracer Label AME and Absolute BA Study (NCT01822041)Aragon Pharmaceuticals, Inc.2013-03-01
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma (NCT02481934)Joaquín Martínez López, MD, PhD2013-03-01
Symptom Burden in Head and Neck Cancer (NCT01219673)M.D. Anderson Cancer Center2013-03-01
The Impact of Proton Pump Inhibitors on the Fecal Microbiome (NCT01822977)Mayo Clinic2013-03-01
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA) (NCT01513902)Pfizer2013-03-01
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium (NCT01906528)University of California, San Francisco2013-03-01
Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg (NCT01817725)Chang Gung Memorial Hospital2013-03-01
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma (NCT01800071)Cancer Research UK2013-03-01
L-citrulline Supplementation, Cold Exposure, & Post-Exercise Muscle Ischemia (NCT02104375)Florida State University2013-03-01
Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers (NCT01796431)St Stephens Aids Trust2013-03-01
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) (NCT02014051)SymBio Pharmaceuticals2013-03-01
Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study (NCT01810549)University of Zurich2013-03-01
Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. (NCT01779687)Radboud University Medical Center2013-03-01
An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction (NCT01846468)Novartis Pharmaceuticals2013-03-01
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics (NCT01806376)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2013-03-01
A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer (NCT01801930)Otsuka Pharmaceutical Co., Ltd.2013-03-01
Efficacy of Intravenous Levetiracetam in Neonatal Seizures (NCT01720667)Richard H. Haas2013-03-01
D-cycloserine and Treatment of Feeding Disorders (NCT01923896)Emory University2013-03-01
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients (NCT01820442)USWM, LLC (dba US WorldMeds)2013-03-01
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies (NCT01781429)BioMed Valley Discoveries, Inc2013-03-01
Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy (NCT02814110)Medical University of Bialystok2013-03-01
Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy (NCT01895062)5i Sciences, Inc.2013-03-01
Topical Safety Study of Topical Diltiazem Hydrochloride (NCT01816529)Ventrus Biosciences, Inc2013-03-01
A Study of Nasal Glucagon in Participants With a Common Cold (NCT02778100)Eli Lilly and Company2013-03-01
IPI-145 ADME and Absolute Bioavailability Study (NCT01836861)SecuraBio2013-03-01
A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation (NCT01821079)Pfizer2013-03-01
Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer (NCT01784757)Orion Corporation, Orion Pharma2013-03-01
Pharmacokinetic Study of Levosulpiride (NCT02481583)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2013-03-01
Experimental Human Rhinovirus Infection (NCT01823640)Radboud University Medical Center2013-03-01
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome (NCT02112253)The University of Western Australia2013-03-01
A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes (NCT02273258)Sanofi2013-03-01
Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca® (NCT01822028)Actelion2013-03-01
Occupational Therapy-Delivered Cognitive Behavioral Therapy for Symptomatic Knee Osteoarthritis (NCT02498847)University of Michigan2013-03-01
"Nanotechnologies Applied to General Surgery and Emergency Surgery: Buckypaper as a New Fixing Method for Prosthetic Materials for the Treatment of Hernia and Incisional Hernia in Laparotomy and Laparoscopic (NCT02137018)University of Roma La Sapienza2013-03-01
A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus (NCT01789788)Hoffmann-La Roche2013-03-01
Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers (NCT02506881)Biocad2013-03-01
Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years (NCT01834664)Chaitanya Hospital, Pune2013-03-01
Pharmacokinetics of Faldaprevir of Soft Capsule (NCT01821937)Boehringer Ingelheim2013-03-01
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer (NCT01632306)Eli Lilly and Company2013-03-01
PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects. (NCT01685333)Azidus Brasil2013-02-28
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration (NCT01692171)Azidus Brasil2013-02-28
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant (NCT01685359)Azidus Brasil2013-02-28
Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide (NCT01692717)Azidus Brasil2013-02-28
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea (NCT01868373)Baylor College of Medicine2013-02-28
Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (NCT01933568)The Netherlands Cancer Institute2013-02-28
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients (NCT01735968)Novartis Pharmaceuticals2013-02-27
A Study of ARGX-110 in Participants With Advanced Malignancies (NCT01813539)OncoVerity, Inc.2013-02-27
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer (NCT01778803)Verastem, Inc.2013-02-26
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) (NCT01573338)Bayer2013-02-25
Rosuvastatin Calcium Bioequivalence Study - Fast (NCT01711749)GlaxoSmithKline2013-02-25
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation (NCT01700751)Washington University School of Medicine2013-02-25
Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) (NCT01910662)GlaxoSmithKline2013-02-22
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers (NCT01818024)GlaxoSmithKline2013-02-22
Patient-centred Home-based Management of Heart Failure (NCT03655496)CareLigo AB2013-02-22
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes (NCT01796366)Novo Nordisk A/S2013-02-21
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients (NCT01702064)H. Lee Moffitt Cancer Center and Research Institute2013-02-21
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia (NCT01794702)M.D. Anderson Cancer Center2013-02-20
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib (NCT01776723)H. Lee Moffitt Cancer Center and Research Institute2013-02-20
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.